To our knowledge, the present study is the first comprehensive study showing that administration of cucurbitacin B not only produces significant antidepressant-like effects in the CUMS model of depression but also reverses the CUMS-induced dysfunction in the hippocampal BDNF signaling cascade and neurogenesis. This evidence concerns the gene BDNF and major depressive disorder.